Whether it's about promoting protein or smaller portions, the restaurant industry is preparing for a shift in consumer ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...

Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...

GLP-1 medications have reached a level of household penetration that food and beverage brands can no longer ignore, but the impact on grocery sales is unfolding more gradually than some might expect.

More people are paying out-of-pocket for GLP-1 weight loss drugs — and more retailers are offering discounts on Zepbound, Ozempic, and Wegovy. Walmart will offer in-store pickup for Zepbound at ...

The GLP-1 market is a massive opportunity in healthcare, and many companies are vying for a piece of it. Healthcare companies have been feverishly working on developing GLP-1 weight loss products in ...

A comprehensive meta-analysis of 91 clinical trials involving more than 100,000 patients showed no increased risk for suicidal ideation or other psychiatric adverse events with GLP-1 receptor agonist ...

GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.

Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors were linked to lower risks for CKD and AKI but greater risks for albuminuria vs. GLP-1s. Risk ...

Patients using GLP-1 agonists had a significantly lower hysterectomy rate over 2-year and 5-year follow-up. Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin ...